Abramson Cancer Center at Penn Medicine: Colorectal Neoplasms trials
The registry lists 12 Colorectal Neoplasms studies with Abramson Cancer Center at Penn Medicine as lead sponsor. 1 are open to participants now and 3 have results posted.
Phase 1 2Phase 2 1No phase 9(a study in two phases counts in both)
Studies
Open to participants first, then studies with results posted, then the rest; newest registration first within each.
- AI-informed Colorectal Cancer (CRC) Screening Navigation vs. Standard of Care Among Screening-naive Penn Medicine Patients 45-49 Years Old to Increase CRC Screening UptakeEnrolling by invitationNCT07230795Not applicable
- Improving Colorectal Cancer Screening in Racially Diverse Zip Codes Using Navigation and Machine Learning (PCSNaP)CompletedNCT05383976Results posted
- Mailed FIT Outreach 2022CompletedNCT05341622Not applicableResults posted
- To Determine the Safety of Regorafenib, Hydroxychloroquine, and Entinostat Metastatic Colorectal CancerCompletedNCT03215264Phase 1Results posted
- Behavioral Economic Approaches for Population-Based Colorectal Cancer ScreeningActive, not recruitingNCT05693649Not applicable
- Preliminary Investigation of β-hydroxybutyrate Supplementation in Colorectal Cancer PreventionActive, not recruitingNCT05338307Not applicable
- TACE Plus Axitinib and Hydroxychlorquine for Liver-Dominant Metastatic Colorectal Cancer (CRC)TerminatedNCT04873895Phase 1
- Shared Decision-making and Colorectal Cancer ScreeningCompletedNCT04748380Not applicable
- Choice Architecture and Mailed Colorectal Cancer Screening Outreach in a Community Health SettingCompletedNCT04711473Not applicable
- Circulating Tumor Material in Colorectal Cancer and MelanomaCompletedNCT02907086
- A Study Of TeleGenetics Versus Usual Care To Increase Access To Cancer Genetic ServicesCompletedNCT02517554
- MRI in Predicting Response in Patients Receiving Combination Chemotherapy and Bevacizumab For Advanced or Metastatic Colorectal CancerTerminatedNCT00602329Phase 2